Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Triple Marker Test- Beckman (Benetech) is typically 5-7 business days from the date of sample collection.

What are the prerequisites for the test Triple Marker Test- Beckman (Benetech)

  • Patient should be between 15 to 20 weeks pregnant
  • Patient should not have any history of diabetes
  • Patient should not have any history of chronic kidney disease
  • Patient should not have any history of liver disease
  • Patient should not have any history of hypertension

What are the measure values for the test Triple Marker Test- Beckman (Benetech)

Measure Value
Alpha-fetoprotein (AFP) 0-2.5 MoM
Human chorionic gonadotropin (hCG) 0-2.5 MoM
Unconjugated estriol (uE3) 0-2.5 MoM

What does this test Triple Marker Test- Beckman (Benetech) identify?

  • The Triple Marker Test- Beckman (Benetech) is a prenatal screening test that helps identify the risk of certain chromosomal abnormalities in the fetus.
  • It measures the levels of three specific substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3).
  • Abnormal levels of these substances can indicate a higher risk of conditions such as Down syndrome, trisomy 18, and neural tube defects.
  • The test is typically performed between 15 and 20 weeks of pregnancy and can help healthcare providers determine if further diagnostic testing, such as amniocentesis or chorionic villus sampling, is necessary.

Why is this test Triple Marker Test- Beckman (Benetech) taken?

The Triple Marker Test is taken to assess the risk of certain genetic abnormalities in a developing fetus. This test measures the levels of three substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3). Abnormal levels of these substances can indicate a higher risk of conditions such as Down syndrome, spina bifida, and other chromosomal abnormalities.

No FAQs available.

Customer Google Rating